Galenica Expands Consumer Offering With Deal For Herbals Specialist Padma
Executive Summary
Switerland's Galenica has bolstered its OTC offering by acquiring local player Padma and its portfolio of OTCs and supplements inspired by Tibetan medicine.
You may also be interested in...
Sustainable And Ethical VMS Will Drive Consumer Health M&A In 2024
Dietary supplement brands with sustainable and ethical credentials are expected to be popular M&A targets for consumer health firms in 2024, but macroeconomic conditions will likely keep overall deal activity relatively low.
Galenica Outpaces Swiss OTC Market Growth In First Half
Galenica's Verfora grows its share of the Swiss consumer health market to 10.2% as its sales jump by 14.1% in the opening six months of 2023.
Omicron And Acquisitions Push Up Galenica's Swiss OTC Sales By A Third
Galenica's Verfora substantially outpaced the 6.4% growth rate of the Swiss consumer health market in the first half, posting sales up by a third thanks to a combination of acquisitions and increased demand for cold & flu products due to the spread of the COVID-19 Omicron variant.